Rationale for a Titratable Fixed-Ratio Co-Formulation of a Basal Insulin Analog and a Glucagon-Like Peptide 1 Receptor Agonist in Patients With Type 2 Diabetes

Current Medical Research and Opinion - United Kingdom
doi 10.1080/03007995.2018.1541790
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Informa UK Limited

Related search

The Association of the Treatment With Glucagon-Like Peptide-1 Receptor Agonist Exenatide or Insulin With Cardiovascular Outcomes in Patients With Type 2 Diabetes: A Retrospective Observational Study

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2015English

Glucagon-Like Peptide 1 Receptor Agonists: A New Approach to Type 2 Diabetes Management

South African Family Practice
2013English

Combining Basal Insulin Analogs With Glucagon-Like Peptide-1 Mimetics

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2011English

Patient Preferences for Frequency of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Injections in the Treatment of Type 2 Diabetes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Gastrointestinal Adverse Events of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2015English

Glucagon-Like Peptide Analogues for Type 2 Diabetes Mellitus

2007English

Glucagon-Like Peptide-1 (7-37) Augments Insulin Release in Elderly Patients With Diabetes

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2001English

The Key Role of a Glucagon-Like Peptide-1 Receptor Agonist in Body Fat Redistribution

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials to the Overall Type 2 Diabetes Population in the United States

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy